PATRICK BEHNKE: Open Payments
NPI 1417490772 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,828 in 299 payments from 22 companies in 2025. Trend: 2023 $9,281 · 2024 $19,046 · 2025 $18,828
Speaker / faculty: $13,650Food & beverage: $4,239Travel & lodging: $756Education: $182
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 22 | $9,310 |
| Galderma Laboratories, L.P. | 28 | $5,809 |
| ABBVIE INC. | 49 | $667 |
| PFIZER INC. | 33 | $439 |
| Janssen Biotech, Inc. | 28 | $397 |
| Arcutis Biotherapeutics, Inc. | 25 | $267 |
| Incyte Corporation | 12 | $260 |
| Regeneron Healthcare Solutions, Inc. | 10 | $254 |
| UCB, Inc. | 15 | $239 |
| Novartis Pharmaceuticals Corporation | 17 | $229 |
Products named: EBGLYSS, NEMLUVIO, CIBINQO, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, Zoryve.
Industry payments across MO — which companies pay providers there.
